Tiny, three-dimensional organoid models are reshaping cancer research by recreating the intricate architecture and diversity ...

Novocure (NASDAQ: NVCR) announced that final results from the Phase 3 METIS trial of Tumor Treating Fields (TTFields) therapy for brain metastases from non-small cell lung cancer (NSCLC) will be ...

A new study finds that GLP-1 medications are linked to lower overall cancer risk, particularly for endometrial and ovarian ...

Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients with R/M-HNSCC naïve or resistant to ...

Scientists discovered that inhibiting the enzyme STK17B forces multiple myeloma cells into iron-driven death and makes ...

Utidelone, previously received orphan drug designation from the FDA for the treatment of breast cancer brain metastases and gastric cancer. The U.S. Food and Drug Administration (FDA) has reportedly ...

Biostar Pharma, Inc., the US wholly-owned subsidiary of Beijing Biostar Biopharmaceutical Co., Ltd. ('Biostar,' stock code: 2563.HK) which is a synthetic biology driven biopharma company focusing on ...

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, and Hemispherian AS, a Norwegian ...

Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma ...

Researchers found that by combining immunotherapy with the drug indisulam, they could achieve a complete therapeutic response ...

Discover how Capricor Therapeutics’ CAP-1002 targets DMD cardiomyopathy. Learn about upcoming data, approval prospects, and ...

Patti’s team is watching them closely, tracking which fish develop tumours, to try to find clues to one of the most unsettling medical puzzles of our time: Why are so many young people getting cancer?